Fact checked by Nick Blackmer The Food and Drug Administration (FDA) recently approved a new targeted chemotherapy drug for ...

A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs ...

Giving patients with a common form of breast cancer an immunotherapy drug before surgery appears to boost outcomes, a n ...

Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations ...

A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved – almost ...

In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive disease by 46% and ...

This approach aims to improve treatment for patients with this highly aggressive and treatment-resistant type of breast ...

The green light from the European Medicines Agency is the first backing in the EU for the medicine, following its approval in ...

Trusted resource of information on Breast Cancer that includes articles, news, videos, animations, quizzes, health calculators and drugs.